Related Experiment Video
Updated: Mar 25, 2026

13:21
Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
10.7K
HMM-DM: identifying differentially methylated regions using a hidden Markov model.
Statistical Applications in Genetics and Molecular Biology
|February 18, 2016
Summary
We developed HMM-DM, a new method for identifying differentially methylated regions in DNA using bisulfite sequencing data. This approach improves upon existing methods for disease-related epigenetic studies.
Area of Science:
- Epigenetics
- Genomics
- Bioinformatics
Background:
- DNA methylation is a key epigenetic modification regulating gene expression, crucial for development and differentiation.
- Identifying differential DNA methylation patterns aids in understanding genomic regions linked to various diseases.
- Bisulfite sequencing (BS) technology enables single-CpG resolution methylation analysis, but efficient statistical methods for region detection are lacking.
Purpose of the Study:
- To develop and validate an efficient statistical method for identifying differentially methylated (DM) regions in bisulfite sequencing data.
- To address the limitations of existing methods in detecting DM regions by accounting for spatial correlation and sample variation.
Main Methods:
- A novel approach, HMM-DM, was developed using a hidden Markov model (HMM).
- HMM-DM first identifies differentially methylated CpG sites, considering spatial correlation and inter-sample variability.
- Identified DM sites are then aggregated into differentially methylated regions.
Main Results:
- HMM-DM demonstrated superior performance compared to the BSmooth method in simulation studies.
- The method effectively identifies differentially methylated regions from bisulfite sequencing data.
Conclusions:
- HMM-DM provides an efficient and accurate approach for detecting differentially methylated regions in BS data.
- This method has practical applications in studying disease-associated genomic alterations, as shown in a breast cancer dataset analysis.

